30 Day Trial

AMNIOX Introduces RESPINA Matrix for Microdiscectomy

Share:

AMNIOX Medical introduced RESPINA™ cryopreserved umbilical cord/amniotic membrane matrix, with application in microdiscectomy.

Results from a randomized, controlled trial indicate that RESPINA enhanced surgical outcomes in microdiscectomy, improving function and reducing pain and incidence of re-herniation.

Through a small incision, microdiscectomy removes herniated lumbar disc material, relieving pressure on the spinal cord and nerves. RESPINA has demonstrated an ability to reduce local inflammation and potential adhesions. AMNIOX seeks to investigate other orthopaedic and spine applications for the matrix.

Source: Amniox Medical, Inc.